Literature DB >> 19563835

Hepatitis B virus immunotolerant patients: need to differentiate patients with or without liver disease.

Manoj Kumar, Shiv K Sarin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19563835     DOI： 10.1053/j.gastro.2009.05.058

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  6 in total

1.  Chronic hepatitis B: the demise of the 'inactive carrier' phase.

Authors:  Apostolos Koffas; Manoj Kumar; Upkar S Gill; Ankur Jindal; Patrick T F Kennedy; S K Sarin
Journal:  Hepatol Int       Date:  2021-02-27       Impact factor: 6.047

2.  Circulating Tregs correlate with viral load reduction in chronic HBV-treated patients with tenofovir disoproxil fumarate.

Authors:  Nirupma TrehanPati; Shyam Kotillil; Syed S Hissar; Shikha Shrivastava; Arshi Khanam; Sukriti Sukriti; Siddartha K Mishra; Shiv Kumar Sarin
Journal:  J Clin Immunol       Date:  2011-02-09       Impact factor: 8.317

Review 3.  Early Treatment Consideration in Patients with Hepatitis B 'e' Antigen-Positive Chronic Infection: Is It Time for a Paradigm Shift?

Authors:  Apostolos Koffas; Lung-Yi Mak; Upkar S Gill; Patrick T F Kennedy
Journal:  Viruses       Date:  2022-04-26       Impact factor: 5.818

Review 4.  Fibrosis assessment: impact on current management of chronic liver disease and application of quantitative invasive tools.

Authors:  Yan Wang; Jin-Lin Hou
Journal:  Hepatol Int       Date:  2016-01-07       Impact factor: 6.047

5.  Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

Authors:  S K Sarin; M Kumar; G K Lau; Z Abbas; H L Y Chan; C J Chen; D S Chen; H L Chen; P J Chen; R N Chien; A K Dokmeci; Ed Gane; J L Hou; W Jafri; J Jia; J H Kim; C L Lai; H C Lee; S G Lim; C J Liu; S Locarnini; M Al Mahtab; R Mohamed; M Omata; J Park; T Piratvisuth; B C Sharma; J Sollano; F S Wang; L Wei; M F Yuen; S S Zheng; J H Kao
Journal:  Hepatol Int       Date:  2015-11-13       Impact factor: 6.047

6.  Quantitative HBsAg versus HBV DNA in Predicting Significant Hepatitis Activity of HBeAg-Positive Chronic HBV Infection.

Authors:  Zhanqing Zhang; Wei Lu; Dong Zeng; Dan Huang; Weijia Lin; Li Yan; Yanling Feng
Journal:  J Clin Med       Date:  2021-11-29       Impact factor: 4.241
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.